NCT03535883View on ClinicalTrials.gov

The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants

CompletedOBSERVATIONAL

Enrollment

590

Participants

Timeline

Start Date

October 30, 2017

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions

Pleural EffusionThoracic Effusion

Interventions

DRUG

Novel Oral Anti-Coagulants

Novel Oral Anti-Coagulant (NOAC) medications (i.e. Eliquis, Plavix, Xarelto etc.)

Trial Locations (1)

06510

Yale New Haven Hospital, New Haven

All Listed Sponsors

lead

Yale University

OTHER

NCT03535883 - The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants | Biotech Hunter | Biotech Hunter